05-23-0101 Sigma-AldrichAngiotensin II, Human - CAS 4474-91-3 - Calbiochem
Plays an important role in the regulation of blood pressure.
More>> Plays an important role in the regulation of blood pressure. Less<<Sinonimi: DRVYIHPF
Prodotti consigliati
Panoramica
| Replacement Information |
|---|
Tabella delle specifiche principali
| CAS # | Empirical Formula |
|---|---|
| 4474-91-3 | C₅₀H₇₁N₁₃O₁₂ |
Prezzi e disponibilità
| Numero di catalogo | Disponibilità | Confezionamento | Qtà/conf | Prezzo | Quantità | |
|---|---|---|---|---|---|---|
| 05-23-0101-1MG |
|
Fiala di plastica | 1 mg |
|
— | |
| 05-23-0101-25MG |
|
Bottiglia di vetro | 25 mg |
|
— | |
| 05-23-0101-5MG |
|
Fiala di plastica | 5 mg |
|
— |
| Product Information | |
|---|---|
| CAS number | 4474-91-3 |
| ATP Competitive | N |
| Form | White to off-white solid |
| Hill Formula | C₅₀H₇₁N₁₃O₁₂ |
| Chemical formula | C₅₀H₇₁N₁₃O₁₂ |
| Hygroscopic | Hygroscopic |
| Reversible | N |
| Sold on the basis of peptide content | Y |
| Quality Segment | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | adenylate cyclase activity |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Peptide Content | Y |
| Peptide Sequence | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | BW2165000 |
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade ITEM Number | |
|---|---|
| Numero di catalogo | GTIN |
| 05-23-0101-1MG | 04055977206906 |
| 05-23-0101-25MG | 04055977206913 |
| 05-23-0101-5MG | 04055977206920 |
Documentation
Angiotensin II, Human - CAS 4474-91-3 - Calbiochem MSDS
| Titolo |
|---|
Angiotensin II, Human - CAS 4474-91-3 - Calbiochem Certificati d'Analisi
| Titolo | Numero di lotto |
|---|---|
| 05-23-0101 |
Riferimenti bibliografici
| Panoramica delle referenze |
|---|
| Zhu, M., et al. 2000. J. Neurophysiol. 84, 2494. Natarajan, R., et al. 1999. Hypertension 33, 378. Mazzolai, L., et al. 1998. Hypertension 31, 1324. Earp, H.S., et al. 1995. J. Biol. Chem. 270, 28440. Ishida, M., et al. 1995. Circ. Res. 77, 1053. Vyas, S.J., and Jackson, E.K. 1995. J. Pharmacol. Exp. Ther. 273, 768. |



